9 Hrs
Source:
البيان
UAE oncology drug pact
“Adcan Pharma” and “M42” have signed a memorandum of understanding to explore collaboration in advanced pharmaceutical manufacturing and clinical research, with a focus on oncology medicines and contract pharmaceutical development and manufacturing services. The first phase includes secondary packaging and the supply of medicines for export, following Glenmark’s completion of a quality audit of Adcan Pharma’s facility. Next steps include facilitating the registration in the UAE of an advanced cancer therapy in the antibody-drug conjugate class. The collaboration will also support clinical trials led by Insights Research & Solutions, with the aim of connecting research and development with local manufacturing and international markets, and strengthening Abu Dhabi’s life sciences ecosystem.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)